Ayurvedic Management Of Fatty Liver

Phase 2

• Conditions: Health Condition 1: K760- Fatty (change of) liver, not elsewhere classified

• Registration Number: CTRI/2019/06/019499
• Lead Sponsor: Patanjali Ayurveda College

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

1.Patients between the age group of 18-65 years will be selected.

2.Patients irrespective of sex, religion, occupation and chronicity will be selected for the study.

3.Both fresh and treated cases would be taken for the study.

4.Patients with higher LFT levels than the upper limit of normal value will be selected.

5.Patients with GRADE 1 and GRADE 2 fatty liver will be selected for the study.

6.Patient with control Diabetes mellitus having GRADE 1 and GRADE 2 fatty liver will be selected for the study.

Exclusion Criteria

1.Patients aged <18 years or >65 years will be excluded.

2.Pregnant or lactating women will be excluded.

3.Patients who had hepatitis B, C or other hepatic viral infection, autoimmune hepatitis and drug-induced hepatitis or alcoholic hepatitis will be excluded.

4.Patients with severe complications of the cardiovascular, renal or hematopoietic systems and mental diseases will be excluded.

5.Patients will be excluded having decompensated liver disease.

6.Patients with prolonged or a history of ascites, developed hepato-cellular carcinoma, hepatic encephalopathy, variceal bleeding will be excluded.

7.Patients with a history of using IFN or antiviral agents or corticosteroids or immunosuppressive drugs will also be excluded.

8.Patients having GRADE 3 fatty liver disease will be excluded.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
All investigations like SGOT, SGPT, Alkaline Phosphates, UltrasonographyTimepoint: Before intervention and follow-up at 1 month

Secondary Outcome Measures

Name	Time	Method
All investigations like SGOT, SGPT, Alkaline Phosphates, UltrasonographyTimepoint: After intervention at 2 months